Blog

$Drew Moghanaki: Roswell Park’s 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT)$

Photo taken from Drew Moghanaki/X

Dec 30, 2023, 17:33

Drew Moghanaki: Roswell Park’s 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT)

Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on X/Twitter:

“Roswell Park’s 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT) is reported (n=263). Local failures include post-treatment scars that grew more than 20% and had FDG-avidity as bright as pre-treatment. Once again, the treatment site control rates mirror almost all multi-fraction lung SBRT studies.”

$Drew Moghanaki: Roswell Park's 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT) 1$

Read further.
Source: Drew Moghanaki/X

cancer Drew Moghanaki FDG-avidity Lung cancer OncoDaily Oncology Roswell Park Stereotactic body radiation therapy (SBRT) UCLA Health Jonsson Cancer Center

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

Karen Knudsen: Clinical trials are the most advanced form of cancer care

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results